RGNX Investors Have Opportunity to Lead REGENXBIO, Inc. Securities Fraud Lawsuit

B NEW YORK, April 3, 2026 /PRNewswire/ —  Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of REGENXBIO, Inc. (NASDAQ:…
posteditor
posteditor
Articles: 16137

Other News